Note 12 - Goodwill and Intangible Assets, net (Details Textual) $ in Thousands |
12 Months Ended | |
|---|---|---|
|
Dec. 31, 2024
USD ($)
|
Dec. 31, 2023
USD ($)
|
|
| Goodwill, Impairment Loss | $ 13,653 | $ 13,895 |
| Impairment of Intangible Assets, Finite-Lived | (13,899) | |
| Amortization of Intangible Assets | 1,709 | $ 1,337 |
| Healthcare Operations [Member] | ||
| Goodwill, Impairment Loss | 700 | |
| Impairment of Intangible Assets, Finite-Lived | $ 12,800 | |
| Healthcare Operations [Member] | Measurement Input, Long-Term Revenue Growth Rate [Member] | ||
| Intangible Assets, Measurement Input | 0.03 | |
| Healthcare Operations [Member] | Measurement Input, Weighted Average Cost of Capital [Member] | ||
| Intangible Assets, Measurement Input | 0.135 | |
| X | ||||||||||
- Definition Represents measurement inputs for intangible assets. No definition available.
|
| X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|